Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Novel Transcription Factor CREB3L4 Contributes to the Progression of Human Breast Carcinoma

6 Feb 2020

Abstract excerpt

Breast carcinoma(BC)is the most common cancer type among females globally. Understanding the molecular pathways that trigger the development of BC is crucial for both prevention and treatment. As such, the role of transcription factors (TFs) in the development of BC is a focal point in this field. CREB3s play a critical role in initiating the unfolded protein response (UPR); however, the role of CREB3 family...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Endoplasmic Reticulum Stress and Disease
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32026099
DOI: 10.1007/s10911-020-09443-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Novel Transcription Factor CREB3L4 Contributes to the Progression of Human Breast CarcinomaPMID 32026099Read ↗

Regulatory mechanisms of the cAMP-responsive element binding protein 3 (CREB3) family in cancers.Semantic proximity Read ↗

Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancersSemantic proximity Read ↗

Reduced CREB3L2 expression is associated with resistance to sorafenib and poor prognosis in ER-positive breast cancerSemantic proximity Read ↗

Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer.Semantic proximity Read ↗

The impact of CBP expression in estrogen receptor-positive breast cancerSemantic proximity Read ↗

Role and regulation of FOXO3a: new insights into breast cancer therapySemantic proximity Read ↗

Breast cancer biomarkers identified in the Gene Expression Omnibus and The Cancer Genome AtlasSemantic proximity Read ↗

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatmentSemantic proximity Read ↗

Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer PatientsSemantic proximity Read ↗

3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.Semantic proximity Read ↗

Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancerSemantic proximity Read ↗

Construction and validation of a prognostic risk model for breast cancer based on protein expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.